Skip to content

Clinical trials

Phase 2/3 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 2/3 Country / region: Italy Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20081
20091
20131
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Not yet recruiting1
Recruiting1
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bambino Gesù Hospital and Research Institute1
Bristol-Myers Squibb1
Gamida Cell -Teva Joint Venture Ltd.1
Gilead Sciences1
Gruppo Italiano Trapianto di Midollo Osseo1
Kiadis Pharma1
Northern Italy Leukemia Group1
St. Anna Kinderkrebsforschung1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3
Graft vs Host Disease2
Hematologic Neoplasms2
Leukemia, Myeloid, Acute2
Lymphoma2
Lymphoma, Non-Hodgkin2
Myelodysplastic Syndromes2
Anemia, Refractory, with Excess of Blasts1
Bronchiolitis Obliterans Syndrome1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.